<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-14T04:18:23Z</responseDate>
  <request identifier="oai:figshare.com:article/33828274" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33828274</identifier>
        <datestamp>2026-09-16T05:42:13Z</datestamp>
        <setSpec>category_24352</setSpec>
        <setSpec>category_24355</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Identification of a Novel ArnT Inhibitor That Restores Polymyxin B Susceptibility in &lt;i&gt;Klebsiella pneumoniae&lt;/i&gt; by Blocking Lipid A Modification</dc:title>
          <dc:creator>Song Yongbo (24833242)</dc:creator>
          <dc:subject>Bacteriology</dc:subject>
          <dc:subject>Infectious agents</dc:subject>
          <dc:subject>Polymyxin B</dc:subject>
          <dc:subject>Klebsiella pneumoniae</dc:subject>
          <dc:subject>ArnT</dc:subject>
          <dc:subject>virtual screening</dc:subject>
          <dc:subject>Antibiotic adjuvant</dc:subject>
          <dc:subject>Lipid A modification</dc:subject>
          <dc:description>&lt;p dir="ltr"&gt;&lt;a href="" target="_blank"&gt;Polymyxin B is the last resort against the worsening antimicrobial resistance of bacterial, but its clinical application is threatened by drug resistance, particularly in &lt;i&gt;Klebsiella pneumoniae&lt;/i&gt;. &lt;/a&gt;&lt;a href="" target="_blank"&gt;Therefore, &lt;/a&gt;developing adjuvants that can restore polymyxin B sensitivity is urgently needed. ArnT is a critical lipid A modifying enzyme that alters the surface properties of LPS, thereby inducing resistance to polymyxin B and assisting bacteria in evading attacks from the human immune system. This study used AlphaFold2 to predict the structure of ArnT in &lt;i&gt;K. pneumoniae&lt;/i&gt; and the virtual screening from a million-compound library to discovered that nonyl β-D-glucopyranoside (NG) is an effective inhibitor of ArnT. The strong affinity of NG for the ArnT active site, composed of residues I138, L182, E241, R245, and Y316, was verified &lt;i&gt;in vitro&lt;/i&gt; and &lt;i&gt;in vivo&lt;/i&gt;. It represents the primary mechanism by which NG restores polymyxin B susceptibility in &lt;i&gt;K. pneumoniae&lt;/i&gt;. Furthermore, this compound comprehensively enhances the antibacterial efficacy of the antibiotic through multiple synergistic pathways, including strengthening antibiotic-induced membrane damage, disrupting proton motive force homeostasis, inhibiting efflux pump activity, and reducing intracellular ATP supply. These findings identify NG as a potential sensitizer for polymyxin B, providing novel therapeutic strategies and theoretical foundations for treating infections caused by polymyxin-resistant &lt;i&gt;K. pneumoniae&lt;/i&gt;.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-16T05:42:13Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.6084/m9.figshare.33828274.v1</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Identification_of_a_Novel_ArnT_Inhibitor_That_Restores_Polymyxin_B_Susceptibility_in_i_Klebsiella_pneumoniae_i_by_Blocking_Lipid_A_Modification/33828274</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
